Clinical and Molecular Findings in Patients with Knobloch Syndrome 1: Case Series Report

Overview

Journal Genes (Basel)

Publisher MDPI

Date 2024 Oct 26

PMID 39457419

Authors

Tatyana Vasilyeva

Vitaly Kadyshev

Olga Khalanskaya

Svetlana Kuznetsova

Sofya Ionova

Andrey Marakhonov

Rena Zinchenko

Affiliations

Soon will be listed here.

Abstract

Background/objectives: Knobloch syndrome 1 (KS) is an autosomal recessive inherited ocular syndrome characterized by a combination of high myopia, vitreoretinal degeneration, and occipital encephalocele. KS is caused by biallelic pathogenic variants in the gene. Diagnosing KS can be challenging due to its clinical heterogeneity and the rarity of the syndrome.

Methods: We conducted comprehensive clinical and instrumental ophthalmological examinations, whole-exome sequencing, Sanger sequencing, and segregation analysis to evaluate affected families.

Results: Two patients presenting with high myopia, low visual acuity, chorioretinal atrophy, and occipital skin/skull defects were diagnosed with Knobloch syndrome 1 (KS). In Case 1, a 14-year-old boy, the variants identified were c.2673dup and c.3523_3524del in a compound heterozygous state. Case 2 involved a 3-year-old girl, the c.1637_1638dup and c.3523_3524del variants were identified in a compound heterozygous state. In Case 3, a retrospectively observed boy of 3 y.o. with KS, the variants c.929-2A>G and c.3523_3524del were defined earlier.

Conclusions: We confirmed KS molecularly in two novel families. Additionally, in Case 3 of a retrospectively analyzed third family and in both novel cases, one of the biallelic causative variants was the same known 2bp deletion in exon 40 of the collagen XVIII gene. Cases 1 and 3 were characterized by connective tissue dysplasia features and a pathognomonic Knobloch triad. No neurological manifestations and no trends in the genotype-phenotype relationship were found. The heterogeneity of phenotype in the case series is likely to be the result of further factors and/or genetic background.

References

Jeong H, Lee D, Negishi K, Tsubota K, Kurihara T . Establishment of an in vitro choroid complex system for vascular response screening. Sci Rep. 2024; 14(1):16129. PMC: 11245503. DOI: 10.1038/s41598-024-67069-8. View

Tomita Y, Shao Z, Cakir B, Kotoda Y, Fu Z, Smith L . An Ex Vivo Choroid Sprouting Assay of Ocular Microvascular Angiogenesis. J Vis Exp. 2020; (162). PMC: 8655367. DOI: 10.3791/61677. View

Paisan-Ruiz C, Scopes G, Lee P, Houlden H . Homozygosity mapping through whole genome analysis identifies a COL18A1 mutation in an Indian family presenting with an autosomal recessive neurological disorder. Am J Med Genet B Neuropsychiatr Genet. 2009; 150B(7):993-7. DOI: 10.1002/ajmg.b.30929. View

Xu M, Shen Y, Han X, Liu C, Jiang Q, Cao X . "One stone and two birds" strategy to treat neovascular age-related macular degeneration by a novel retinoid drug, EYE-101. Exp Eye Res. 2023; 227:109385. DOI: 10.1016/j.exer.2023.109385. View

Gatseva A, Sin Y, Brezzo G, Van Agtmael T . Basement membrane collagens and disease mechanisms. Essays Biochem. 2019; 63(3):297-312. PMC: 6744580. DOI: 10.1042/EBC20180071. View

Jiang Z, Sun W, Zhang Q, Wang P . Generation of an induced pluripotent stem cell line (ZSZOCi001-A) from a patient with Knobloch syndrome caused by biallelic mutations in the gene COL18A1. Stem Cell Res. 2023; 70:103131. DOI: 10.1016/j.scr.2023.103131. View

Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae J, Fazel Darbandi S, Knowles D, Li Y . Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2019; 176(3):535-548.e24. DOI: 10.1016/j.cell.2018.12.015. View

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J . Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015; 17(5):405-24. PMC: 4544753. DOI: 10.1038/gim.2015.30. View

Kliemann S, Waetge R, Suzuki O, Rita Passos-Bueno M, Rosemberg S . Evidence of neuronal migration disorders in Knobloch syndrome: clinical and molecular analysis of two novel families. Am J Med Genet A. 2003; 119A(1):15-9. DOI: 10.1002/ajmg.a.20070. View

10.

Levinger N, Hendler K, Banin E, Hanany M, Kimchi A, Mechoulam H . Variable phenotype of Knobloch syndrome due to biallelic mutations in children. Eur J Ophthalmol. 2020; 31(6):3349-3354. DOI: 10.1177/1120672120977343. View

11.

Pufe T, Petersen W, Miosge N, Goldring M, Mentlein R, Varoga D . Endostatin/collagen XVIII--an inhibitor of angiogenesis--is expressed in cartilage and fibrocartilage. Matrix Biol. 2004; 23(5):267-76. DOI: 10.1016/j.matbio.2004.06.003. View

12.

Hull S, Arno G, Ku C, Ge Z, Waseem N, Chandra A . Molecular and Clinical Findings in Patients With Knobloch Syndrome. JAMA Ophthalmol. 2016; 134(7):753-62. DOI: 10.1001/jamaophthalmol.2016.1073. View

13.

Zech T, Wolf A, Hector M, Bischoff-Kont I, Krishnathas G, Kuntschar S . 2-Desaza-annomontine (C81) impedes angiogenesis through reduced VEGFR2 expression derived from inhibition of CDC2-like kinases. Angiogenesis. 2024; 27(2):245-272. PMC: 11021337. DOI: 10.1007/s10456-024-09906-y. View

14.

Iozzo R, Zoeller J, Nystrom A . Basement membrane proteoglycans: modulators Par Excellence of cancer growth and angiogenesis. Mol Cells. 2009; 27(5):503-13. PMC: 6712562. DOI: 10.1007/s10059-009-0069-0. View

15.

Caglayan A, Baranoski J, Aktar F, Han W, Tuysuz B, Guzel A . Brain malformations associated with Knobloch syndrome--review of literature, expanding clinical spectrum, and identification of novel mutations. Pediatr Neurol. 2014; 51(6):806-813.e8. PMC: 5056964. DOI: 10.1016/j.pediatrneurol.2014.08.025. View

16.

Fomo K, Perumal N, Manicam C, Pfeiffer N, Grus F . Neuroretinal Cell Culture Model as a Tool for the Development of New Therapeutic Approaches for Oxidative Stress-Induced Ocular Diseases, with a Focus on Glaucoma. Cells. 2024; 13(9. PMC: 11083839. DOI: 10.3390/cells13090775. View

17.

Keren B, Suzuki O, Gerard-Blanluet M, Bremond-Gignac D, Elmaleh M, Titomanlio L . CNS malformations in Knobloch syndrome with splice mutation in COL18A1 gene. Am J Med Genet A. 2007; 143A(13):1514-8. DOI: 10.1002/ajmg.a.31784. View

18.

Feng Y, Wang L, Dong C, Yang X, Wang J, Zhang X . MicroRNA-376b-3p Suppresses Choroidal Neovascularization by Regulating Glutaminolysis in Endothelial Cells. Invest Ophthalmol Vis Sci. 2023; 64(1):22. PMC: 9896860. DOI: 10.1167/iovs.64.1.22. View

19.

Passos-Bueno M, Suzuki O, Armelin-Correa L, Sertie A, Errera F, Bagatini K . Mutations in collagen 18A1 and their relevance to the human phenotype. An Acad Bras Cienc. 2006; 78(1):123-31. DOI: 10.1590/s0001-37652006000100012. View

20.

Mettu P, Allingham M, Cousins S . Incomplete response to Anti-VEGF therapy in neovascular AMD: Exploring disease mechanisms and therapeutic opportunities. Prog Retin Eye Res. 2020; 82:100906. PMC: 10368393. DOI: 10.1016/j.preteyeres.2020.100906. View